Antihyperglycemic treatment patterns for chronic kidney disease and type 2 diabetes.
Keith A BettsNikolaus G OberprielerAozhou WuGlen JamesScott BeemanAlain GayXuanhao HeDavid Vizcaya
Published in: The American journal of managed care (2024)
Treatment of T2D was considerably heterogenous by HbA1C level and CKD severity in patients with incident CKD. Current agents may not sufficiently fulfill the unmet need of T2D management in patients with CKD.